Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

DHT may increase the risk of heart disease and death in elderly men.

High doses of finasteride cause cell growth and tumors in mice.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Finasteride causes abnormal growth in male mice cells at high doses.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Finasteride and metformin both help treat PCOS, but using them together works best.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Spironolactone treatment increases the amount of testosterone available in the body.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Baicalin may help reduce excessive male hormone levels in PCOS.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.